Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre study - Maza, S; Gellrich, S; Assaf, C (Leuk Lymphoma, 2008)
et al.